Blinded continuous monitoring of nuisance parameters in clinical trials

Journal of the Royal Statistical Society. Series C: Applied Statistics

Volumn 61, Issue 4, 2012, Pages 601-618

  Friede, Tim ^a   Miller, Frank ^b  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Clinical trials; Continuous monitoring; Sample size re estimation; Sequential designs

Indexed keywords

EID: 84864078220     PISSN: 00359254     EISSN: 14679876     Source Type: Journal    
DOI: 10.1111/j.1467-9876.2011.01029.x     Document Type: Article

References (36)

1. Anscombe, F. J. (1953) Sequential estimation. J. R. Statist. Soc. B, 15, 1-21.
2. Benda, N., Branson, M., Maurer, W. and Friede, T. (2010) Aspects of modernizing drug development using clinical scenario planning and evaluation. Drug Inform. J., 44, 299-315.
3. Birkett, M. A. and Day, S. J. (1994) Internal pilot studies for estimating sample size. Statist. Med., 13, 2455-2463.
4. Brown Stafford, P. and Garrett, A. (2011) Using real-time data to drive better decisions, faster. Drug Inform. J., 45, 495-502.
5. Chow, Y. S. and Robbins, H. (1965) On the asymptotic theory of fixed width sequential confidence intervals for the mean. Ann. Math. Statist., 36, 457-462.
6. Chuang-Stein, C., Anderson, K., Gallo, P. and Collins, S. (2006) Sample size re-estimation, a review and recommendations. Drug Inform. J., 40, 475-484.
7. Coffey, C. S. and Muller, K. E. (1999) Exact test size and power of a Gaussian error linear model for an internal pilot study. Statist. Med., 18, 1199-1214.
8. Committee for Medicinal Products for Human Use (2007). Report CHMP/EWP/2459/02. European Medicines Agency, London. (Available from.)
9. Day, S. J. and Altman, D. G. (2000) Blinding in clinical trials and other studies. Br. Med. J., 321, 504.
10. Denne, J. S. and Jennison, C. (1999) Estimating the sample size for a t test using an internal pilot. Statist. Med., 18, 1575-1585.
11. Denne, J. S. and Jennison, C. (2000) A group sequential t-test with updating of sample size. Biometrika, 87, 125-134.
12. Eales, J. D. and Jennison, C. (1992) An improved method for deriving optimal one-sided group sequential tests. Biometrika, 79, 13-24.
13. Food and Drug Administration (2010) Guidance for Industry: Adaptive Design Clinical Trials for Drugs and Biologics. Rockville: Food and Drug Administration. (Available from.)
14. Friede, T. and Kieser, M. (2001) A comparison of methods for adaptive sample size adjustment. Statist. Med., 20, 3861-3873.
15. Friede, T. and Kieser, M. (2003) Blinded sample size reassessment in non-inferiority and equivalence trials. Statist. Med., 22, 995-1007.
16. Friede, T. and Kieser, M. (2006) Sample size recalculation in internal pilot study designs: a review. Biometr. J., 48, 537-555.
17. Gaertner, J., Elsner, F., Pollmann-Dahmen, K., Radbruch, L. and Sabatowski, R. (2004) Electronic pain diary: a randomized crossover study. J. Pain Symptm Mangmnt, 28, 259-267.
18. Jennison, C. and Turnbull, B. W. (2007) Adaptive seamless designs: selection and prospective testing of hypotheses. J. Biopharm. Statist., 17, 1135-1161.
19. Kieser, M. and Friede, T. (2000) Recalculating the sample size in internal pilot study designs with control of the type I error rate. Statist. Med., 19, 901-911.
20. Kieser, M. and Friede, T. (2003) Simple procedures for blinded sample size adjustment that do not affect the type I error rate. Statist. Med., 22, 3571-3581.
21. Krams, M., Lees, K. R., Hacke, W., Grieve, A. P., Orgogozo, J. M. and Ford, G. A. for the ASTIN Study Investigators (2003) Acute stroke therapy by inhibition of neutrophils (ASTIN): an adaptive dose-response study of UK-279, 276 in acute ischemic stroke. Stroke, 34, 2543-2548.
22. MacDonald, T. M., Reginster, J.-Y., Littlejohn, T. W., Richard, D., Lheritier, K., Krammer, G. and Rebuli, R. (2008) Effect on blood pressure of lumiracoxib versus ibuprofen in patients with osteoarthritis and controlled hypertension: a randomized trial. J. Hypertensn, 26, 1695-1704.
23. Mehta, C. R. and Tsiatis, A. A. (2001) Flexible sample size considerations using information-based interim monitoring. Drug Inform. J., 35, 1095-1112.
24. Miller, F. (2005) Variance estimation in clinical studies with interim sample size reestimation. Biometrics, 61, 355-361.
25. Phillips, A. J. and Keene, O. N. (2006) Adaptive designs for pivotal trials: discussion points from the PSI Adaptive Design Expert Group. Pharm. Statist., 5, 61-66.
26. Proschan, M. (2009) Sample size re-estimation in clinical trials. Biometr. J., 51, 348-357.
27. Schulz, K. F. and Grimes, D. A. (2002) Blinding in randomised trials: hiding who got what. Lancet, 359, 696-700.
28. Siegmund, D. (1985) Sequential Analysis. New York: Springer.
29. Sowers, J. R., White, W. B., Pitt, B., Whelton, A., Simon, L. S., Winer, N., Kivitz, A., van Ingen, H., Brabant, T. and Fort, J. G. for the Celecoxib Rofecoxib Efficacy and Safety in Comorbidities Evaluation Trial (CRESCENT) Investigators (2005) The effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 Diabetes Mellitus. Arch. Intern. Med., 165, 161-168.
30. Starr, N. (1966) The performance of a sequential procedure for the fixed width interval estimation of the mean. Ann. Math. Statist., 37, 36-50.
31. Stein, C. (1945) A two-sample test for a linear hypothesis whose power is independent of the variance. Ann. Math. Statist., 16, 243-258.
32. Stone, A. and Broderick, J. E. (2007) Real-time data collection for pain: appraisal and current status. Pain Med., 8, suppl., S85-S93.
33. Tsiatis, A. A. (2006) Information-based monitoring of clinical trials. Statist. Med., 25, 3236-3244.
34. White, W. B., Kent, J., Taylor, A., Verburg, K. M., Lefkowith, J. B. and Whelton, A. (2002) Effects of celecoxib on ambulatory blood pressure in hypertensive patients on ACE inhibitors. Hypertension, 39, 929-934.
35. Wittes, J. and Brittain, E. (1990) The role of internal pilot studies in increasing the efficiency of clinical trials. Statist. Med., 18, 3493-3509.
36. Wittes, J., Schabenberger, O., Zucker, D., Brittain, E. and Proschan, M. (1999) Internal pilot studies I: Type I error rate of the naive t-test. Statist. Med., 18, 3481-3491.